Avanzi, M. P., Yeku, O., Li, X., Wijewarnasuriya, D. P., van Leeuwen, D. G., Cheung, K., . . . Brentjens, R. J. (2018). Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System. Cell reports (Cambridge), 23(7), 2130-2141. https://doi.org/10.1016/j.celrep.2018.04.051
Citácia podle Chicago (17th ed.)Avanzi, Mauro P., et al. "Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and Through Activation of the Endogenous Immune System." Cell Reports (Cambridge) 23, no. 7 (2018): 2130-2141. https://doi.org/10.1016/j.celrep.2018.04.051.
Citácia podľa MLA (8th ed.)Avanzi, Mauro P., et al. "Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and Through Activation of the Endogenous Immune System." Cell Reports (Cambridge), vol. 23, no. 7, 2018, pp. 2130-2141, https://doi.org/10.1016/j.celrep.2018.04.051.